Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
BMC Psychiatry ; 23(1): 482, 2023 06 29.
Article in English | MEDLINE | ID: mdl-37386462

ABSTRACT

BACKGROUND: Antipsychotic treatment may improve clinical insight. However, previous studies have reported inconclusive findings on whether antipsychotics improve insight over and above the reduction in symptoms of psychosis. These studies assessed homogeneous samples in terms of stage of illness. Randomised studies investigating a mixed population of first- and multiepisode schizophrenia spectrum disorders might clarify this disagreement. METHODS: Our data were derived from a pragmatic, rater-blinded, semi-randomised trial that compared the effectiveness of amisulpride, aripiprazole and olanzapine. A sample of 144 patients with first- or multiepisode schizophrenia spectrum disorders underwent eight assessments during a 1-year follow-up. Clinical insight was assessed by item General 12 from the Positive and Negative Syndrome Scale (PANSS). We analysed latent growth curve models to test if the medications had a direct effect on insight that was over and above the reduction in total psychosis symptoms. Furthermore, we investigated whether there were differences between the study drugs in terms of insight. RESULTS: Based on allocation analysis, all three drugs were associated with a reduction in total psychosis symptoms in the initial phase (weeks 0-6). Amisulpride and olanzapine were associated with improved insight over and above what was related to the reduction in total psychosis symptoms in the long-term phase (weeks 6-52). However, these differential effects were lost when only including the participants that chose the first drug in the randomisation sequence. We found no differential effect on insight among those who were antipsychotic-naïve and those who were previously medicated with antipsychotics. CONCLUSIONS: Our results suggest that antipsychotic treatment improves insight, but whether the effect on insight surpasses the effect of reduced total psychosis symptoms is more uncertain. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01446328, 05.10.2011.


Subject(s)
Antipsychotic Agents , Schizophrenia , Humans , Schizophrenia/drug therapy , Olanzapine/therapeutic use , Aripiprazole/therapeutic use , Antipsychotic Agents/therapeutic use , Amisulpride/therapeutic use
2.
Schizophr Res ; 246: 49-59, 2022 08.
Article in English | MEDLINE | ID: mdl-35709647

ABSTRACT

Antipsychotic medications are generally effective in ameliorating psychotic symptoms in schizophrenia spectrum disorders (SSDs). Identifying predictors associated with poor treatment response is important for a personalized treatment approach. Childhood trauma (CT) may have a general and differential effect on the effectiveness of different types of antipsychotics in SSDs. The Bergen-Stavanger-Trondheim-Innsbruck (BeSt InTro) study is a pragmatic, researcher-initiated, semi-randomized trial. The present study aimed to investigate symptom change (the Positive and Negative Syndrome Scale) from baseline to 1, 3, 6, 12, 26, 39 and 52 weeks of antipsychotic treatment (amisulpride, aripiprazole and olanzapine) by group (CT/no CT). Participants (n = 98) with diagnoses within the schizophrenia spectrum (F20-29 in the International Classification of Diseases - 10th Revision) were randomized to receive amisulpride, aripiprazole or olanzapine, and for this study categorized into groups of none and low CT, and moderate to severe CT according to thresholds defined by the Childhood Trauma Questionnaire Short-Form manual. CT in SSDs predicted an overall slower treatment response and less antipsychotic effectiveness after 26 weeks of treatment, which was statistically nonsignificant at 52 weeks. Secondary analyses showed a differential effect of CT related to type of antipsychotic medication: patients with SSDs and CT who received olanzapine showed less antipsychotic effectiveness throughout 52 weeks of treatment. The intention-to-treat and per-protocol analyses were convergent. Our findings indicate that in patients with SSD and CT, delayed response to antipsychotics could be expected, and a longer evaluation period before considering change of medication may be recommended.


Subject(s)
Adverse Childhood Experiences , Antipsychotic Agents , Schizophrenia , Amisulpride/therapeutic use , Antipsychotic Agents/therapeutic use , Aripiprazole/therapeutic use , Benzodiazepines/therapeutic use , Humans , Olanzapine/therapeutic use , Prospective Studies , Risperidone/therapeutic use , Schizophrenia/chemically induced , Schizophrenia/complications , Schizophrenia/drug therapy
3.
Schizophr Res Cogn ; 21: 100179, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32461919

ABSTRACT

Childhood trauma (CT) is a risk factor for schizophrenia spectrum disorders (SSDs), and cognitive impairment is a core feature and a vulnerability marker of SSDs. Studies of the relationship between CT and cognitive impairment in SSDs are inconclusive. In addition, few studies have examined differential effects of CT subtypes, e.g. physical, sexual or emotional abuse/neglect, on cognitive functioning. The present study therefore aimed to examine the effects of CT and CT subtypes on cognitive impairment in SSD. Participants (n = 78) with SSDs completed a comprehensive neuropsychological test battery and the Childhood Trauma Questionnaire Short-Form (CTQ-SF). We compared global cognitive performance as well as scores in seven subdomains (verbal abilities, visuospatial abilities, learning, memory, attention/working memory, executive abilities and processing speed) between participants reporting no CT and those reporting CT experiences using independent samples t-tests as well as linear regression analyses to control for possible confounders. CT subtype physical neglect was associated with attention and working memory after controlling for positive and negative psychosis symptoms, years of education, antipsychotics, gender and age, and adjustment of multiple testing. Our results indicate that the observed heterogeneity in cognitive impairment in SSDs, especially attention/working memory abilities, may in part be associated with childhood physical neglect.

4.
J Psychiatr Res ; 103: 219-228, 2018 08.
Article in English | MEDLINE | ID: mdl-29890508

ABSTRACT

Depression is common in schizophrenia and associated with negative outcomes. Previous studies have identified heterogeneity in treatment response in schizophrenia. We aimed to investigate different trajectories of depression in patients suffering from psychosis and predictors of change in depressive symptoms during antipsychotic treatment. Two hundred and twenty-six patients >18 years acutely admitted due to psychosis were consecutively included and the follow-up was 27 weeks. The Calgary Depression Scale for Schizophrenia (CDSS) sum score was the primary outcome. Latent growth curve (LGCM) and Growth Mixture Models (GMM) were conducted. Predictors were the Positive sum score of the Positive and Negative Syndrome Scale for Schizophrenia (PANSS), Schizophrenia spectrum/non-spectrum psychoses, gender and being antipsychotic naive at inclusion. We found support for three depression-trajectories, including a high- (14.7%), a low depression-level (69.6%) class and a third depressed class quickly decreasing to a low level (15.7%). Change in CDSS was associated with change in PANSS positive score in all time intervals (4 weeks: b = 0.18, p < 0.001, 3 months: 0.21, p < 0.023, 6 months: 0.43, p < 0.001) and with a diagnosis within schizophrenia spectrum but not with antipsychotic naivety or gender. The schizophrenia-spectrum patients had less depressive symptoms at inclusion (-2.63, p < 0.001). In conclusion, an early responding and a treatment refractory group were identified. The treatment-refractory patients are candidates for enhanced anti-depressive treatment, for which current evidence is limited. The post-psychotic depression group was characterized by depressive symptoms in the acute phase as well. We could not identify differentiating characteristics of the depression trajectories.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/etiology , Depression/therapy , Schizophrenia/complications , Schizophrenia/drug therapy , Adult , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prospective Studies , Psychiatric Status Rating Scales , Sex Factors
5.
Dis Markers ; 2018: 5046372, 2018.
Article in English | MEDLINE | ID: mdl-29651324

ABSTRACT

BACKGROUND: After perinatal asphyxia, the cerebellum presents more damage than previously suggested. OBJECTIVES: To explore if the antioxidant N-acetylcysteine amide (NACA) could reduce cerebellar injury after hypoxia-reoxygenation in a neonatal pig model. METHODS: Twenty-four newborn pigs in two intervention groups were exposed to 8% oxygen and hypercapnia, until base excess fell to -20 mmol/l or the mean arterial blood pressure declined to <20 mmHg. After hypoxia, they received either NACA (NACA group, n = 12) or saline (vehicle-treated group, n = 12). One sham-operated group (n = 5) served as a control and was not subjected to hypoxia. Observation time after the end of hypoxia was 9.5 hours. RESULTS: The intranuclear proteolytic activity in Purkinje cells of asphyxiated vehicle-treated pigs was significantly higher than that in sham controls (p = 0.03). Treatment with NACA was associated with a trend to decreased intranuclear proteolytic activity (p = 0.08), There were significantly less mutations in the mtDNA of the NACA group compared with the vehicle-treated group, 2.0 × 10-4 (±2.0 × 10-4) versus 4.8 × 10-5(±3.6 × 10-4, p < 0.05). CONCLUSION: We found a trend to lower proteolytic activity in the core of Purkinje cells and significantly reduced mutation rate of mtDNA in the NACA group, which may indicate a positive effect of NACA after neonatal hypoxia. Measuring the proteolytic activity in the nucleus of Purkinje cells could be used to assess the effect of different neuroprotective substances after perinatal asphyxia.


Subject(s)
Acetylcysteine/analogs & derivatives , Asphyxia Neonatorum/drug therapy , Neuroprotective Agents/administration & dosage , Purkinje Cells/drug effects , Acetylcysteine/administration & dosage , Acetylcysteine/pharmacology , Animals , Asphyxia Neonatorum/genetics , DNA, Mitochondrial/drug effects , DNA, Mitochondrial/genetics , Disease Models, Animal , Humans , Infant, Newborn , Mutation Rate , Neuroprotective Agents/pharmacology , Proteolysis , Purkinje Cells/cytology , Purkinje Cells/metabolism , Swine
6.
Psychol Med ; 46(15): 3127-3136, 2016 11.
Article in English | MEDLINE | ID: mdl-27534999

ABSTRACT

BACKGROUND: Cannabis use disorder is associated with an earlier age at onset and a more severe outcome of schizophrenia spectrum disorders. The role of cannabis use before the onset of illness (premorbid cannabis use) has not been fully investigated. We here examined how amount and type of premorbid cannabis use was associated with the later course of illness including current substance use, symptoms and level of functioning in schizophrenia spectrum disorder. METHOD: We used a naturalistic sample of patients with DSM-IV schizophrenia spectrum disorders with a comprehensive history of illness and substance use. Data on premorbid substance use was obtained from comprehensive self-report. The relationship to outcome was investigated using regression models that included current substance use and premorbid functioning. RESULTS: Pre-schizophrenia cannabis use was significantly associated with more severe psychotic symptoms and impaired functioning. Higher levels of premorbid cannabis use were associated with higher levels of current psychotic symptoms. These associations were independent of current substance use and premorbid functioning. Early use of cannabis (age <17 years) was associated with earlier age at onset of psychosis, independently of potential confounders. CONCLUSIONS: Pre-psychosis cannabis use affects illness outcome in schizophrenia spectrum disorders, and is associated with lower age at onset of psychosis. These findings of independent negative effects of premorbid cannabis use in schizophrenia suggest that a limitation of the general use of cannabis may have beneficial health effects.


Subject(s)
Marijuana Abuse/psychology , Marijuana Smoking/psychology , Psychotic Disorders/psychology , Schizophrenia/physiopathology , Schizophrenic Psychology , Adult , Amphetamine-Related Disorders/epidemiology , Amphetamine-Related Disorders/psychology , Cocaine-Related Disorders/epidemiology , Cocaine-Related Disorders/psychology , Female , Humans , Male , Marijuana Abuse/epidemiology , Marijuana Smoking/epidemiology , Norway/epidemiology , Psychotic Disorders/epidemiology , Schizophrenia/epidemiology , Young Adult
7.
Eur Psychiatry ; 30(7): 830-6, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26443050

ABSTRACT

BACKGROUND: Assessment of suicide risk is crucial in schizophrenia and results concerning risk contributed by hallucinations and persecutory delusions are inconsistent. We aimed to determine factors associated with suicidal ideation and plans at the time of acute admission in patients suffering from schizophrenia spectrum disorders. METHODS: One hundred and twenty-four patients older than 18 years admitted to an acute psychiatric ward due to psychosis were consecutively included. Predictors of suicidal ideation and suicide plans at the time of admission were examined with multinominal logistic regression and structural equation modelling (SEM). The study design was pragmatic, thus entailing a clinically relevant representation. RESULTS: Depression Odds Ratio (OR) 12.9, Drug use OR 4.07, Hallucinations OR 2.55 and Negative symptoms OR 0.88 significantly predicted Suicidal ideation. Suspiciousness/ Persecution did not. Only Depression and Hallucinations significantly predicted Suicide plans. In the SEM-model Anxiety, Depression and Hopelessness connected Suspiciousness/Persecution, Hallucinations and Lack of insight with Suicidal ideation and Suicide plans. CONCLUSIONS: The study contributes to an increasing evidence base supporting an association between hallucinations and suicide risk. We want to emphasise the importance of treating depression and hallucinations in psychotic disorders, reducing hopelessness while working with insight and reducing drug abuse in order to lower suicide risk. TRIAL REGISTRATION: ClinicalTrials.gov ID; URL: http://www.clinicaltrials.gov/NCT00932529.


Subject(s)
Delusions/therapy , Depression/therapy , Hallucinations/therapy , Psychotic Disorders/complications , Psychotic Disorders/therapy , Suicide/psychology , Adult , Delusions/diagnosis , Delusions/etiology , Depression/diagnosis , Depression/etiology , Female , Hallucinations/diagnosis , Hallucinations/etiology , Humans , Male , Middle Aged , Psychiatric Department, Hospital , Psychotic Disorders/diagnosis , Risk Factors , Schizophrenia/diagnosis , Substance-Related Disorders/complications , Suicidal Ideation , Suicide Prevention
8.
Eur Psychiatry ; 28(3): 174-84, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22153730

ABSTRACT

PURPOSE: Cognitive effects of second generation antipsychotics (SGAs) are indicated in efficacy studies but the generalizability of the results may be limited by rigid designs and selected samples. The aim of this naturalistic, industry-independent study is to investigate whether differential neurocognitive effectiveness can be found among olanzapine, quetiapine, risperidone, and ziprasidone in a clinically relevant sample with psychosis. SUBJECTS AND METHODS: Adult patients acutely admitted to an emergency ward for psychosis were randomized to risperidone, olanzapine, quetiapine or ziprasidone and followed for up to 2 years. Participants were assessed repeatedly using the Positive and Negative Syndrome Scale and a repeatable neurocognitive test battery. RESULTS: A total of 226 patients were included and 171 patients underwent neurocognitive assessments. The sample had a global cognitive performance score at baseline about one standard deviation below that of the general population. The ziprasidone group had the fastest increase in global functioning which was significantly superior to that of the olanzapine group for the entire follow-up period. Before 90 days, the quetiapine group had the fastest increase which was statistically superior to the olanzapine group. DISCUSSION: Ziprasidone and quetiapine demonstrated superiority to olanzapine in increasing global neurocognitive performance in this naturalistic sample.


Subject(s)
Antipsychotic Agents/therapeutic use , Benzodiazepines/therapeutic use , Dibenzothiazepines/therapeutic use , Piperazines/therapeutic use , Psychotic Disorders/drug therapy , Risperidone/therapeutic use , Thiazoles/therapeutic use , Adolescent , Adult , Aged , Cognition/drug effects , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Olanzapine , Quetiapine Fumarate , Treatment Outcome , Young Adult
9.
Scand J Immunol ; 69(6): 555-62, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19439017

ABSTRACT

Experimental animal models indicate that complement contributes to tissue damage during brain ischaemia and stroke, but limited data are available for a role of the complement in human stroke. We, therefore, evaluated whether acute ischaemia leads to complement activation in human brain. Indirect immunohistochemical staining was performed on paraffin-embedded, formalin-fixed human brain from 10 patients and 10 controls. Complement components C1q, C3c and C4d were detected in all ischaemic lesions, suggesting activation via the classical pathway. C9, C-reactive protein and IgM were detected in necrotic zones. Marked CD59 and weak CD55 expression were found in normal brains, but these complement regulators were virtually absent in ischaemic lesions. Modest amounts of mannose-binding lectin (MBL), MBL-associated serine protease-2 and factor B were found in both ischaemic lesions and controls. These data suggest that increased deposition of complement components combined with decreased expression of complement regulators is a possible mechanism of tissue damage during ischaemia in human brain.


Subject(s)
Brain Ischemia/immunology , Brain Ischemia/metabolism , Complement Activation/immunology , Complement System Proteins/immunology , Complement System Proteins/metabolism , Adult , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Male , Middle Aged
10.
Acta Radiol ; 49(9): 1049-57, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18720081

ABSTRACT

BACKGROUND: Early detection of hypoxic-ischemic (HI) injury in the asphyxic newborn is important because present prognostic factors are inadequate. Furthermore, therapeutic interventions may have additional benefit if initiated in time. PURPOSE: To assess whether the use of a combined protocol including conventional magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI), and proton MR spectroscopy (MRS) could detect pathological findings in a piglet model 7 hours after HI. MATERIAL AND METHODS: Ten piglets were submitted to HI for 30 min followed by reoxygenation with 21% O2 for 7 hours. MRI at 1.5T was done prior to and 7 hours after the HI. Single-voxel proton MRS was performed, and apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in the basal ganglia. MRS identified N-acetylaspartate (NAA), choline (Cho), creatine (Cr), and lactate (Lac). Histology and microtubule-associated protein 2 (MAP-2) staining was performed in the basal ganglia at the end of the experiment. RESULTS: Compared to baseline, ADC, NAA/Cho, and NAA/Cr were significantly reduced after 7 hours (P<0.001, P=0.01, and P=0.05, respectively) and FA values were increased (P<0.025). The ratios of Lac/Cho and Lac/NAA were significantly higher after 7 hours compared to baseline (P<0.001). Presence of necrosis correlated well with reduced ADC (R(S)=0.91) and presence of Lac (R(S)=0.80). Histology and MAP-2 staining showed more than 90% necrosis in eight piglets, 60% in one piglet, and no necrosis in one piglet. CONCLUSION: Diffusion MRI and proton MRS can detect HI injury in the piglet brain 7 hours after hypoxia. DWI and MRS can be used to give useful prognostic information. This piglet model may potentially be used to mimic clinical situations and is suitable for further research investigating HI injury.


Subject(s)
Diffusion Magnetic Resonance Imaging , Hypoxia-Ischemia, Brain/diagnosis , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Animals , Animals, Newborn , Aspartic Acid/analogs & derivatives , Aspartic Acid/analysis , Basal Ganglia/chemistry , Brain/pathology , Brain Chemistry , Choline/analysis , Creatine/analysis , Disease Models, Animal , Lactic Acid/analysis , Microtubule-Associated Proteins/analysis , Swine
11.
Acta Psychiatr Scand ; 113(4): 322-31, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16638077

ABSTRACT

OBJECTIVE: Dichotic listening (DL) performance in schizophrenia, reflecting hemispheric asymmetry and the functional integrity of the left temporal lobe, can vary with clinical characteristics. Previous studies have not taken the co-linearity of clinical variables into account. The aim of the present study was to evaluate the roles of positive symptoms and duration of illness in DL through Structural Equation Modeling (SEM), thus allowing for complex relationships between the variables. METHOD: We pooled patients from four previous DL studies to create a heterogeneous group of 129 schizophrenic patients, all tested with a consonant-vowel syllables DL procedure that included attentional instructions. RESULTS: A model where positive symptoms predicted a laterality component and duration of illness predicted an attention component in DL was confirmed. CONCLUSION: Positive symptoms predicted reduced functional laterality, suggesting involvement of left temporal lobe language processing. Duration of illness predicted impaired attention modulation, possibly reflecting the involvement of frontotemporal networks.


Subject(s)
Attention/physiology , Brain/physiopathology , Functional Laterality/physiology , Schizophrenia/diagnosis , Schizophrenia/physiopathology , Schizophrenic Psychology , Adolescent , Adult , Brief Psychiatric Rating Scale , Dichotic Listening Tests , Female , Frontal Lobe/physiopathology , Humans , Male , Middle Aged , Phonetics , Predictive Value of Tests , Psychiatric Status Rating Scales , Speech Perception , Temporal Lobe/physiopathology
12.
Gut ; 52(11): 1649-52, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14570737

ABSTRACT

The current trend is to allow coeliac disease (CD) patients to introduce oats to their gluten free diet. We sought further data from the clinical setting with regards to oats consumption by coeliac patients. Several oat products were tested for wheat contamination using a commercial enzyme linked immunoassay (ELISA) kit, and six samples were examined by an ELISA using a cocktail of monoclonal antibodies, mass spectrometry, and western blot analysis. Nineteen adult CD patients on a gluten free diet were challenged with 50 g of oats per day for 12 weeks. Serological testing and gastroduodenoscopy was performed before and after the challenge. Biopsies were scored histologically and levels of mRNA specific for interferon gamma were determined by reverse transcription-polymerase chain reaction analysis. Oats were well tolerated by most patients but several reported initial abdominal discomfort and bloating. One of the patients developed partial villous atrophy and a rash during the first oats challenge. She subsequently improved on an oats free diet but developed subtotal villous atrophy and dramatic dermatitis during a second challenge. Five of the patients showed positive levels of interferon gamma mRNA after challenge. Some concerns therefore remain with respect to the safety of oats for coeliacs.


Subject(s)
Avena/adverse effects , Celiac Disease/pathology , Adult , Atrophy , Blotting, Western/methods , Celiac Disease/metabolism , Diet, Protein-Restricted/methods , Enzyme-Linked Immunosorbent Assay/methods , Female , Glutens/administration & dosage , Glutens/analysis , Humans , Interferon-gamma/analysis , Intestinal Mucosa/pathology , Intestine, Small/pathology , Male , Microvilli/pathology , Middle Aged , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods
13.
Biol Neonate ; 83(2): 146-56, 2003.
Article in English | MEDLINE | ID: mdl-12576759

ABSTRACT

BACKGROUND: Perinatal asphyxia may lead to multiorgan damage as well as brain injury. Posthypoxic hypothermia (HT) may protect other organs in addition to the brain. The aim of this study was to assess the systemic effects of our global hypoxic-ischaemic (HI) insult and compare the effect of mild 24-hour HT with normothermia (NT) during unsedated recovery. METHOD: Thirty-eight newborn pigs were subjected to 45 min of global HI by ventilating them with approximately 6% O2. On reoxygenation, pigs were randomised to NT or HT. The 18 NT piglets were maintained at rectal temperature 39.0 degrees C for 72 h. Twenty-three HT pigs (20 experimental HT and 3 sham controls) were cooled to rectal temperature 35 degrees C for 24 h before NT was resumed and the animals then survived a further 48 h. RESULTS: All lesions were small with no apparent clinical effect. The incidence of any damage to the heart (6 HT vs. 9 NT), liver (9 HT vs. 7 NT), kidney (6 HT vs. 9 NT) or intestinal injury (8 HT vs. 2 NT, p = 0.07) was not different in the two groups. More HT piglets developed lung injury, 10 HT and 3 NT. Plasma [Na], [K], [Ca] and [Mg] increased significantly after the HI insult as compared to baseline values. For the 24-hour period plasma [K] and [Ca] were significantly higher in the HT group, the mean area under the curve (AUC) being for [K] AUC(HT) 4.4 mmol/l vs. AUC(NT) 3.9 mmol/l, p = 0.04 and for [Ca] AUC(HT) 2.7 mmol/l vs. AUC(NT) 2.5 mmol/l, p = 0.01, respectively. Aspartate aminotransferase peaked at 48 h in the HT group and at 24 h in the NT group. Creatinine peaked at >72 h in the HT pigs and at 48 h in the NT pigs. White blood cells (WBC) peaked at 12 h for the HT pigs and at 6 h for the NT animals. AUC of the WBC during the cooling was significantly lower in the HT pig (AUC(HT) 11.1 vs. AUC(NT) 15.3 10(3)/mm3, p = 0.04). The HT pigs needed more glucose to maintain normal glucose during the last 12 h of HT. Also HT animals needed more oxygen during cooling to maintain PaO2. CONCLUSION: Twenty-four hours of mild HT did not reduce damage in any organ. There was a slight increase in lung damage in the HT group. None of the biochemical or pathological changes were of clinical significance. We conclude that mild HT for 24 h does not affect the organ systems adversely when compared to NT. Additional glucose and oxygen is needed during cooling to maintain normal values.


Subject(s)
Animals, Newborn , Brain Ischemia/metabolism , Brain Ischemia/pathology , Hypothermia, Induced , Hypoxia/metabolism , Hypoxia/pathology , Adrenal Glands/metabolism , Adrenal Glands/pathology , Animals , Animals, Newborn/blood , Blood Cell Count , Intestinal Mucosa/metabolism , Intestines/drug effects , Lung/metabolism , Lung/pathology , Myocardium/metabolism , Myocardium/pathology , Survival Analysis , Swine , Time Factors
14.
Brain Pathol ; 11(4): 432-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11556688

ABSTRACT

Rhombencephalitis due to Listeria monocytogenes is characterized by progressive cranial nerve palsies and subacute inflammation in the brain stem. In this paper, we report observations made on mice infected with L. monocytogenes. Unilateral inoculation of bacteria into facial muscle, or peripheral parts of a cranial nerve, induced clinical and histological signs of mainly ipsilateral rhombencephalitis. Similarly, unilateral inoculation of bacteria into lower leg muscle or peripheral parts of sciatic nerve was followed by lumbar myelitis. In these animals, intraaxonal bacteria were seen in the sciatic nerve and its corresponding nerve roots ipsilateral to the bacterial application site. Development of myelitis was prevented by transsection of the sciatic nerve proximally to the hindleg inoculation site. Altogether, our results support the hypothesis that Listeria rhombencephalitis is caused by intraaxonal bacterial spread from peripheral sites to the central nervous system.


Subject(s)
Axons/microbiology , Central Nervous System/microbiology , Listeria monocytogenes/pathogenicity , Meningitis, Listeria/physiopathology , Peripheral Nerves/microbiology , Animals , Axonal Transport/physiology , Axons/metabolism , Axons/pathology , Brain Stem/microbiology , Brain Stem/pathology , Brain Stem/physiopathology , Central Nervous System/pathology , Central Nervous System/physiopathology , Facial Nerve/microbiology , Facial Nerve/pathology , Facial Nerve/physiopathology , Female , Meningitis, Listeria/pathology , Mice , Mice, Inbred ICR , Peripheral Nerves/pathology , Peripheral Nerves/physiopathology , Sciatic Nerve/microbiology , Sciatic Nerve/pathology , Sciatic Nerve/physiopathology , Spinal Cord/microbiology , Spinal Cord/pathology , Spinal Cord/physiopathology
15.
Pediatr Res ; 50(3): 405-11, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11518829

ABSTRACT

Three to 12 h of mild hypothermia (HT) starting after hypoxia-ischemia is neuroprotective in piglets that are anesthetized during HT. Newborn infants suffering from neonatal encephalopathy often ventilate spontaneously and are not necessarily sedated. We aimed to test whether mild posthypoxic HT lasting 24 h was neuroprotective if the animals were not sedated. Thirty-nine piglets (median weight 1.6 kg, range 0.8-2.2 kg; median age 24 h, range 7-48 h) were anesthetized and ventilated and subjected to a 45-min hypoxic (FiO(2) approximately 6%) global insult (n = 36) or sham hypoxia (n = 3). On reoxygenation, 18 were maintained normothermic (NT, 39.0 degrees C) for 72 h, and 21 were cooled from 39 (NT) to 35 degrees C (HT) for the first 24 h before NT was resumed (18 experimental, three sham hypoxia). Cardiovascular parameters and intermittent EEG were documented throughout. The brain was perfusion fixed for neuropathology and five main areas examined using light microscopy. The insult severity (duration in minutes of EEG amplitude < 7 microV) was similar in the NT and HT groups, mean +/- SD (28 +/- 7.2 versus 27 +/- 8.6 min), as was the mean FiO(2) (5.9 +/- 0.7 versus 5.8 +/- 0.8%) during the insult. Six NT and seven HT piglets developed posthypoxic seizures that lasted 29 and 30% of the time, respectively. The distribution and degree of injury (0.0-4.0, normal-maximal damage) within the brain (hippocampus, cortex/white matter, cerebellum, basal ganglia, thalamus) were similar in the NT and HT groups (overall score, mean +/- SD, 2.3 +/- 1.5 versus 2.4 +/- 1.3) as was the EEG background amplitude at 3 h (13 +/- 3.5 versus 10 +/- 3.3 microV). The HT animals shivered and were more active. The sham control group (n = 3) shivered but had normal physiology and neuropathology. Plasma cortisol was significantly higher in the HT group during the HT period, 766 +/- 277 versus 244 +/- 144 microM at 24 h. Mild postinsult HT for 24 h was not neuroprotective in unsedated piglets and did not reduce the number of animals that developed posthypoxic seizures. Cortisol reached 3 times the NT value at the end of HT. We speculate that the stress of shivering and feeling cold interfered with the previously shown neuroprotective effect of HT. Research on the appropriateness of sedation during clinical HT is urgent.


Subject(s)
Brain/pathology , Hypothermia/physiopathology , Hypoxia/physiopathology , Ischemia/physiopathology , Adult , Animals , Animals, Newborn , Body Temperature , Brain/drug effects , Child , Electroencephalography , Female , Humans , Hydrocortisone/blood , Hypnotics and Sedatives/pharmacology , Hypoxia/pathology , Infant, Newborn , Ischemia/pathology , Male , Seizures/physiopathology , Swine
16.
Cancer Res ; 61(13): 5010-5, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11431334

ABSTRACT

The multiple intestinal neoplasia (Min)/+ mouse, which harbors only one functional allele of the Apc gene, is susceptible to environmental factors that disrupt this gene and subsequently trigger Apc-driven tumorigenesis in the colon. Aberrant crypt foci (ACF) are assumed to be preneoplastic lesions in colon carcinogenesis. Recently, we reported the absence of "classical" ACF in the colon of untreated Min/+ mice. Instead we identified flat dysplastic lesions, which we denoted ACF(Min) (J. E. Paulsen et al., Scand. J. Gastroenterol., 35: 534-539, 2000). In contrast to the classical type, ACF(Min) are not elevated above the surrounding mucosa, and their detection is totally dependent on methylene blue staining and transillumination. In the present study, we treated Min/+ mice with 5 mg/kg body weight azoxymethane (AOM) at weeks 1 and 2 and demonstrated induction of both types of lesions. However, only ACF(Min) appeared to be associated with the development of adenomas. Monocryptal ACF(Min), large ACF(Min), and adenomas showed a uniform histopathological picture of dysplasia and cytoplasmic overexpression of beta-catenin, indicating a qualitative relationship between these lesions. Also a quantitative relationship was suggested because the dramatic decrease in ACF(Min) number from week 7 to 11 was paralleled by a reciprocal increase in tumor number, indicating fast-crypt multiplication of ACF(Min). In AOM-treated +/+ (wild-type) littermates, a low number of ACF(Min) and tumors with the same characteristics as in Min/+ mice was seen. In contrast to ACF(Min), histopathological and immunohistochemical examination of classical ACF showed normal or hyperplastic crypts with normal levels of beta-catenin expression. In AOM-treated Min/+ mice, the number of classical ACF was virtually constant from week 7 to 11, and only a modest increase of crypt multiplicity was observed. The number of AOM-induced classical ACF at week 11 was not different in Min/+ mice and +/+ mice. In conclusion, we identified two distinct populations of altered crypts in the colon of Min/+ mice after AOM treatment. The ACF(Min), which resemble the dysplastic ACF described previously, clearly showed a continuous development from the monocryptal stage to adenoma, and they were characterized by fast-growing crypts with altered control of beta-catenin. In contrast, the classical ACF, which resemble the hyperplastic ACF described previously, were characterized by slow-growing crypts with normal beta-catenin expression, and they were probably not related to tumorigenesis.


Subject(s)
Colonic Neoplasms/genetics , Colonic Neoplasms/pathology , Precancerous Conditions/genetics , Precancerous Conditions/pathology , Trans-Activators , Adenoma/genetics , Adenoma/pathology , Adenomatous Polyposis Coli/genetics , Adenomatous Polyposis Coli/pathology , Alleles , Animals , Azoxymethane , Carcinogens , Cell Division/physiology , Cocarcinogenesis , Colonic Neoplasms/chemically induced , Cytoskeletal Proteins/biosynthesis , Female , Genes, APC , Genetic Predisposition to Disease/genetics , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Precancerous Conditions/chemically induced , beta Catenin
17.
Acta Radiol ; 42(1): 114-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11167343

ABSTRACT

Mucinous ductal ectasia is an uncommon disorder, characterized by ductal dilatation and filling with thick, viscid mucus, described in the pancreas. We report a case of mucinous ductal ectasia of the biliary tree. The cause of the mucus production was mucous metaplasia in the biliary epithelium. The patient was followed for 16 years, treated with serial saline flushings of the biliary tree whenever he became symptomatic.


Subject(s)
Common Bile Duct Neoplasms/diagnosis , Common Bile Duct/pathology , Cystadenoma, Mucinous/diagnosis , Aged , Cholangiopancreatography, Endoscopic Retrograde , Diagnosis, Differential , Fatal Outcome , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Metaplasia/pathology , Mucous Membrane/pathology
18.
Tidsskr Nor Laegeforen ; 120(1): 57-61, 2000 Jan 10.
Article in Norwegian | MEDLINE | ID: mdl-10815481

ABSTRACT

Apoptosis is a phenomenon of fundamental importance in embryonal development and the homeostatic regulation of mature tissue. We review the present knowledge on apoptosis and the evidence that apoptosis may play a role in the pathogenesis of human disease. As examples we discuss its role in cancer, ischemic diseases, heart failure and neurodegenerative diseases.


Subject(s)
Apoptosis , Disease , Heart Failure/etiology , Heart Failure/pathology , Heart Failure/physiopathology , Humans , Ischemia/etiology , Ischemia/pathology , Ischemia/physiopathology , Neoplasms/etiology , Neoplasms/pathology , Neoplasms/physiopathology , Neurodegenerative Diseases/etiology , Neurodegenerative Diseases/pathology , Neurodegenerative Diseases/physiopathology
20.
Tidsskr Nor Laegeforen ; 119(3): 373-4, 1999 Jan 30.
Article in Norwegian | MEDLINE | ID: mdl-10074834

ABSTRACT

Rhombencephalitis due to Listeria monocytogenes is a serious form of brainstem inflammation. It is difficult to diagnose on the basis of clinical and laboratory findings alone. We describe a fatal case of Listeria monocytogenes rhombencephalitis in a previously healthy female teenager. Clinical and pathogenetic aspects of this condition are discussed.


Subject(s)
Brain Stem/microbiology , Encephalitis/microbiology , Listeriosis , Meningitis, Listeria/diagnosis , Adolescent , Brain Stem/pathology , Diagnosis, Differential , Encephalitis/diagnosis , Encephalitis/pathology , Fatal Outcome , Female , Humans , Listeriosis/diagnosis , Listeriosis/pathology , Meningitis, Listeria/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...